Looking for tools and templates that will make planned or unplanned retirement and the closing or your practice easier to manage? Carlat Publishing has teamed up with the American Psychiatric Association to create handy toolkits.
While I appreciate all of my TCPR subscribers, there’s one subscriber whom I value above all the others: my father. A psychiatrist who practices in the Bay Area, my father has been a loyal subscriber since Volume 1, Number 1, in January of 2003.
James T. Hilliard, Esq.
Connor & Hilliard, P.C. Assistant Professor (Legal Medicine), Harvard Medical School, part-time.
Mr. Hilliard has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
This article offers practical suggestions based on the author’s experiences counseling psychiatrists who are planning for retirement or who have faced unforeseen circumstances causing them to close their practices. Here, we will consider both planned and unplanned retirement scenarios.
Colin Wiens, CFP, MBA
Senior Financial Advisor, Larson Financial Group, LLC.
Registered Representative, Larson Financial Securities, LLC.
Mr. Wiens discloses that he receives various forms of compensation for financial advising services. Dr. Carlat has reviewed this article and has found no evidence of bias in this educational activity.
Because of the lengthy period of training, doctors begin their first “real” jobs 8–10 years after many of their friends from college. And, depending on specialty, burnout may cause a physician to retire a few years earlier than the average American. Both these factors lead to a compressed retirement saving timeline.
Ricardo Arechiga, PharmD candidate (2018)
Mr. Arechiga has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
It seems like an endless debate: When a patient does not respond to the first trial of an antidepressant, what should we do? Switch to something else? Augment with another agent? If the latter, how often should that augmenting agent be an atypical antipsychotic?
Shirley Tsai
PharmD candidate (2018)
Ms. Tsai has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Somatic symptom disorder (formerly known as hypochondriasis) is pretty common, with a prevalence of 5%–7%, and is much more likely to afflict women than men, with a gender ratio of about 10:1. While both psychotherapy and SSRI treatment are helpful, there is limited evidence about the efficacy of combining therapy with medication. A new study sought to remedy this gap.
The post-test for this issue is available for one year after the publication date to subscribers only. By successfully completing the test you will be awarded a certificate for 1 CME credit.
Julie Gentile, MD
Professor of psychiatry at the Boonshoft School of Medicine, Wright State University. Project director for Ohio’s Coordinating Center of Excellence in Mental Illness & Intellectual Disability.
Dr. Gentile has disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.David Dixon, DO
Clinical chief resident, Wright State University, Department of Psychiatry.
Dr. Dixon has disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Prescribing psychotropic medications in patients with intellectual disability (ID) requires certain nuances in approach that may be unfamiliar to some psychiatrists. In this article, we’ll discuss some aspects of assessment and treatment that you may find useful when you encounter and work with such patients.
KarXT (Cobenfy) is the first antipsychotic that doesn’t block dopamine. We trace the origins of this new drug to a South Asian herb used for over 5,000 years, up to the three...